{"id":42721,"date":"2023-07-31T16:40:35","date_gmt":"2023-07-31T20:40:35","guid":{"rendered":"https:\/\/ifintechworld.com\/investing\/quest-diagnostics-launches-first-at-home-blood-test-to-assess-risk-of-developing-alzheimers-disease\/"},"modified":"2023-07-31T16:40:37","modified_gmt":"2023-07-31T20:40:37","slug":"quest-diagnostics-launches-first-at-home-blood-test-to-assess-risk-of-developing-alzheimers-disease","status":"publish","type":"post","link":"https:\/\/ifintechworld.com\/?p=42721","title":{"rendered":"Quest Diagnostics launches first at-home blood test to assess risk of developing Alzheimer\u2019s disease"},"content":{"rendered":"
\n

Quest Diagnostics Inc. said Monday the first blood-based biomarker test to assess the risk of developing Alzheimer\u2019s disease is now available for consumer purchase. <\/p>\n

The test helps assess the risk of getting the disease based on the brain protein beta amyloid, which is known to accumulate and form plaques in the brain that are linked to the progression of Alzheimer\u2019s disease. <\/p>\n

\n

\u201cAD-Detect is a screening test that uses plasma, the liquid component of blood, from a single blood draw to evaluate levels of amyloid beta proteins to help detect early signs associated with the risk of developing Alzheimer\u2019s disease,\u201d Quest
\n DGX,
\n +0.54%<\/bg-quote>
\n said in a statement. <\/p>\n

The move comes at a time when new treatments for Alzheimer\u2019s are emerging. There\u2019s also growing recognition that non-pharmacological interventions can reduce disease risk, and there\u2019s greater medical acceptance of blood tests to aid early Alzheimer\u2019s disease detection. <\/p>\n

In mid-July, research released by the Alzheimer\u2019s Association International Conference in Amsterdam showed that testing by a simple pin prick to the finger was imminent.<\/p>\n

A test developed by researchers at the University of Gothenburg in Sweden was able to identify proteins and successfully detected those Alzheimer\u2019s biomarkers in blood that had been collected from memory-clinic patients in Barcelona, transferred to dry blood-spot cards, and shipped overnight to Sweden without any special temperature controls, according to the research.\u00a0<\/p>\n

Current methods of diagnosing Alzheimer\u2019s include positron emission tomography (PET) brain-imaging scans and analysis of cerebrospinal fluid, which can be expensive and invasive.\u00a0<\/p>\n

For more, read: <\/strong>At-home Alzheimer\u2019s testing is on the horizon, researchers say\u00a0<\/p>\n

Also in July, FDA\u00a0approved the Biogen Inc.\u00a0
\n BIIB,
\n +1.87%<\/bg-quote>
\n and Eisai Co. Ltd.
\n ESALF,
\n -0.86%<\/bg-quote>
\n \u00a0drug Leqembi, which reduces amyloid plaques in the brain.\u00a0<\/p>\n

And Eli Lilly & Co.
\n LLY,
\n -0.86%<\/bg-quote>
\n said its investigational Alzheimer\u2019s treatment donanemab has shown particular promise in treating patients at younger ages and in the earliest stage of disease, according to new late-stage trial results released Monday.\u00a0<\/p>\n

More than six million Americans have been diagnosed with Alzheimer\u2019s, which is the most common form of dementia. That number is expected to climb to 14 million by 2060. <\/p>\n

For more information:<\/strong> The highest rates of Alzheimer\u2019s are in these U.S. counties, new research shows<\/p>\n

Quest\u2019s stock was down 0.6% Monday and has fallen 14% in the year to date, while the S&P 500
\n SPX,
\n +0.15%<\/bg-quote>
\n has gained 19%. <\/p>\n<\/p><\/div>\n<\/div>\n

Read the full article here<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Quest Diagnostics Inc. said Monday the first blood-based biomarker test to assess the risk of developing Alzheimer\u2019s disease is now available for consumer purchase. The test helps assess the risk of getting the disease based on the brain protein beta amyloid, which is known to accumulate and form plaques in the brain that are linked […]<\/p>\n","protected":false},"author":1,"featured_media":20741,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"video","meta":{"footnotes":""},"categories":[239],"tags":[83],"class_list":["post-42721","post","type-post","status-publish","format-video","has-post-thumbnail","hentry","category-investing","tag-featured","post_format-post-format-video"],"yoast_head":"\nQuest Diagnostics launches first at-home blood test to assess risk of developing Alzheimer\u2019s disease | iFintechWorld<\/title>\n<meta name=\"description\" content=\"Quest Diagnostics Inc. said Monday the first blood-based biomarker test to assess the risk of developing Alzheimer\u2019s disease is now available for consumer\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ifintechworld.com\/?p=42721\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Quest Diagnostics launches first at-home blood test to assess risk of developing Alzheimer\u2019s disease | iFintechWorld\" \/>\n<meta property=\"og:description\" content=\"Quest Diagnostics Inc. said Monday the first blood-based biomarker test to assess the risk of developing Alzheimer\u2019s disease is now available for consumer\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ifintechworld.com\/?p=42721\" \/>\n<meta property=\"og:site_name\" content=\"iFintechWorld\" \/>\n<meta property=\"article:published_time\" content=\"2023-07-31T20:40:35+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-07-31T20:40:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/06\/1686370423_social.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1279\" \/>\n\t<meta property=\"og:image:height\" content=\"640\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"News Room\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"News Room\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ifintechworld.com\/?p=42721#article\",\"isPartOf\":{\"@id\":\"https:\/\/ifintechworld.com\/?p=42721\"},\"author\":{\"name\":\"News Room\",\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/person\/6224724fd4116361255b179dc5c70b61\"},\"headline\":\"Quest Diagnostics launches first at-home blood test to assess risk of developing Alzheimer\u2019s disease\",\"datePublished\":\"2023-07-31T20:40:35+00:00\",\"dateModified\":\"2023-07-31T20:40:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ifintechworld.com\/?p=42721\"},\"wordCount\":418,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/ifintechworld.com\/#organization\"},\"keywords\":[\"Featured\"],\"articleSection\":[\"Investing\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ifintechworld.com\/?p=42721#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ifintechworld.com\/?p=42721\",\"url\":\"https:\/\/ifintechworld.com\/?p=42721\",\"name\":\"Quest Diagnostics launches first at-home blood test to assess risk of developing Alzheimer\u2019s disease | iFintechWorld\",\"isPartOf\":{\"@id\":\"https:\/\/ifintechworld.com\/#website\"},\"datePublished\":\"2023-07-31T20:40:35+00:00\",\"dateModified\":\"2023-07-31T20:40:37+00:00\",\"description\":\"Quest Diagnostics Inc. said Monday the first blood-based biomarker test to assess the risk of developing Alzheimer\u2019s disease is now available for consumer\",\"breadcrumb\":{\"@id\":\"https:\/\/ifintechworld.com\/?p=42721#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ifintechworld.com\/?p=42721\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ifintechworld.com\/?p=42721#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ifintechworld.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Quest Diagnostics launches first at-home blood test to assess risk of developing Alzheimer\u2019s disease\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ifintechworld.com\/#website\",\"url\":\"https:\/\/ifintechworld.com\/\",\"name\":\"Repay Down\",\"description\":\"Latest Personal Finance News, Tips and Updates\",\"publisher\":{\"@id\":\"https:\/\/ifintechworld.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ifintechworld.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ifintechworld.com\/#organization\",\"name\":\"Repay Down\",\"url\":\"https:\/\/ifintechworld.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/rep-logo-dark.png\",\"contentUrl\":\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/rep-logo-dark.png\",\"width\":558,\"height\":90,\"caption\":\"Repay Down\"},\"image\":{\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/person\/6224724fd4116361255b179dc5c70b61\",\"name\":\"News Room\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/avatar_user_1_1682606986-96x96.png\",\"contentUrl\":\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/avatar_user_1_1682606986-96x96.png\",\"caption\":\"News Room\"},\"sameAs\":[\"https:\/\/ifintechworld.com\"],\"url\":\"https:\/\/ifintechworld.com\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Quest Diagnostics launches first at-home blood test to assess risk of developing Alzheimer\u2019s disease | iFintechWorld","description":"Quest Diagnostics Inc. said Monday the first blood-based biomarker test to assess the risk of developing Alzheimer\u2019s disease is now available for consumer","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ifintechworld.com\/?p=42721","og_locale":"en_US","og_type":"article","og_title":"Quest Diagnostics launches first at-home blood test to assess risk of developing Alzheimer\u2019s disease | iFintechWorld","og_description":"Quest Diagnostics Inc. said Monday the first blood-based biomarker test to assess the risk of developing Alzheimer\u2019s disease is now available for consumer","og_url":"https:\/\/ifintechworld.com\/?p=42721","og_site_name":"iFintechWorld","article_published_time":"2023-07-31T20:40:35+00:00","article_modified_time":"2023-07-31T20:40:37+00:00","og_image":[{"width":1279,"height":640,"url":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/06\/1686370423_social.jpeg","type":"image\/jpeg"}],"author":"News Room","twitter_card":"summary_large_image","twitter_misc":{"Written by":"News Room","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ifintechworld.com\/?p=42721#article","isPartOf":{"@id":"https:\/\/ifintechworld.com\/?p=42721"},"author":{"name":"News Room","@id":"https:\/\/ifintechworld.com\/#\/schema\/person\/6224724fd4116361255b179dc5c70b61"},"headline":"Quest Diagnostics launches first at-home blood test to assess risk of developing Alzheimer\u2019s disease","datePublished":"2023-07-31T20:40:35+00:00","dateModified":"2023-07-31T20:40:37+00:00","mainEntityOfPage":{"@id":"https:\/\/ifintechworld.com\/?p=42721"},"wordCount":418,"commentCount":0,"publisher":{"@id":"https:\/\/ifintechworld.com\/#organization"},"keywords":["Featured"],"articleSection":["Investing"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ifintechworld.com\/?p=42721#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ifintechworld.com\/?p=42721","url":"https:\/\/ifintechworld.com\/?p=42721","name":"Quest Diagnostics launches first at-home blood test to assess risk of developing Alzheimer\u2019s disease | iFintechWorld","isPartOf":{"@id":"https:\/\/ifintechworld.com\/#website"},"datePublished":"2023-07-31T20:40:35+00:00","dateModified":"2023-07-31T20:40:37+00:00","description":"Quest Diagnostics Inc. said Monday the first blood-based biomarker test to assess the risk of developing Alzheimer\u2019s disease is now available for consumer","breadcrumb":{"@id":"https:\/\/ifintechworld.com\/?p=42721#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ifintechworld.com\/?p=42721"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ifintechworld.com\/?p=42721#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ifintechworld.com\/"},{"@type":"ListItem","position":2,"name":"Quest Diagnostics launches first at-home blood test to assess risk of developing Alzheimer\u2019s disease"}]},{"@type":"WebSite","@id":"https:\/\/ifintechworld.com\/#website","url":"https:\/\/ifintechworld.com\/","name":"Repay Down","description":"Latest Personal Finance News, Tips and Updates","publisher":{"@id":"https:\/\/ifintechworld.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ifintechworld.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/ifintechworld.com\/#organization","name":"Repay Down","url":"https:\/\/ifintechworld.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ifintechworld.com\/#\/schema\/logo\/image\/","url":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/rep-logo-dark.png","contentUrl":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/rep-logo-dark.png","width":558,"height":90,"caption":"Repay Down"},"image":{"@id":"https:\/\/ifintechworld.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ifintechworld.com\/#\/schema\/person\/6224724fd4116361255b179dc5c70b61","name":"News Room","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ifintechworld.com\/#\/schema\/person\/image\/","url":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/avatar_user_1_1682606986-96x96.png","contentUrl":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/avatar_user_1_1682606986-96x96.png","caption":"News Room"},"sameAs":["https:\/\/ifintechworld.com"],"url":"https:\/\/ifintechworld.com\/?author=1"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/posts\/42721","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=42721"}],"version-history":[{"count":1,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/posts\/42721\/revisions"}],"predecessor-version":[{"id":42722,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/posts\/42721\/revisions\/42722"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/media\/20741"}],"wp:attachment":[{"href":"https:\/\/ifintechworld.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=42721"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=42721"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=42721"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}